Companies: 10,795·Total market cap: $144.5T
BioSyntech, Inc.

BioSyntech, Inc.

BSYIOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$229033
P/E Ratio—
52W High$0.00001
52W Low$0.000001
EarningsFinancialsRevenue

BioSyntech, Inc. (BSYI) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

BSYI · earnings · updated Jun 9, 2026

Latest Earnings

Q4 FY2007
EPS Actual
-$0.02
Est. -$0.01 · -33.3%
Revenue
—
Fiscal Period
Q4 FY2007
FY ends December
Report Date
Nov 12, 2007
After Market Close
▼ Miss EPS
BSYI reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)
Actual (Miss)
Estimated

Earnings History

Q4 FY2007
Nov 12, 2007Miss
EPS Actual
-$0.02
EPS Est.
-$0.01
EPS Surpr.
-33.3%
Revenue
—
Q3 FY2007
Aug 13, 2007
EPS Actual
-$0.02
EPS Est.
-$0.02
EPS Surpr.
+0.0%
Revenue
—
No analyst estimates available for BSYI.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.
Q4 FY2007+13.64%
Report Date
Nov 12, 2007
EPS Beat/Miss
-33.3%
Price Before
$0.33
Price After
$0.38
Q3 FY2007+4.60%
Report Date
Aug 13, 2007
EPS Beat/Miss
+0.0%
Price Before
$0.48
Price After
$0.50
Avg Beat Reaction+4.60%
Avg Miss Reaction+13.64%
Beat Rate1 / 2 quarters
Largest Move+13.64% (Q4 FY2007)
Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: BSYI ends December

BioSyntech, Inc. (BSYI) most recently reported earnings on November 12, 2007 for Q4 FY2007, posting EPS of $-0.02 — missing the analyst consensus of $-0.01 by -33.3%. The next BSYI earnings date is expected around September 1, 2026.

Each quarter, investors track BSYI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BSYI revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BSYI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

BSYI earnings · 5 questions

BioSyntech, Inc.'s next earnings report is expected around September 1, 2026. BSYI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BSYI historically reports after market close (AMC).

BSYI earnings datewhen is BSYI earningsBSYI next earnings datewhen does BSYI report earningsBSYI earnings calendar

▸ Source: FMP · BioSyntech, Inc. SEC filings · US GAAP · BioSyntech, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026